Oncopeptides AB (publ) (ONPPF) Stock Analysis
DELISTED
What happened to Oncopeptides AB (publ) (ONPPF) stock?
Oncopeptides AB (publ) (ONPPF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $56.0M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Oncopeptides AB (publ) (ONPPF). Oncopeptides AB (publ) is a Swedish biotech company focused on developing targeted therapies for difficult-to-treat cancers. Their lead product candidate, melflufen, aims to improve outcomes for patients with relapsed refractory multiple myeloma.
Last analyzed: Mar 17, 2026Oncopeptides AB (publ) (ONPPF) Healthcare & Pipeline Overview
ONPPF OTC Market Information
ONPPF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ONPPF shares?
No. ONPPF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ONPPF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ONPPF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Oncopeptides AB (publ). An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.